112 related articles for article (PubMed ID: 16061554)
1. cDNA microarray analysis assists in diagnosis of malignant intrarenal pheochromocytoma originally masquerading as a renal cell carcinoma.
Takahashi M; Yang XJ; McWhinney S; Sano N; Eng C; Kagawa S; Teh BT; Kanayama HO
J Med Genet; 2005 Aug; 42(8):e48. PubMed ID: 16061554
[TBL] [Abstract][Full Text] [Related]
2. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
3. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
[No Abstract] [Full Text] [Related]
4. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
6. Significance of gene expression analysis of renal cell carcinoma.
Leppert JT; Pantuck AJ
Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
[TBL] [Abstract][Full Text] [Related]
7. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
Ozawa N; Okamura T; Koyama K; Hamazawa Y; Senzaki H; Tanabe S; Ikemoto S; Inoue Y
Ann Nucl Med; 2007 Jun; 21(4):239-43. PubMed ID: 17581724
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
11. Classification of renal neoplasms based on molecular signatures.
Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
14. Does 'granular cell' renal cell carcinoma exist? Molecular and histological reclassification.
Yang XJ; Takahashi M; Schafernak KT; Tretiakova MS; Sugimura J; Vogelzang NJ; Teh BT
Histopathology; 2007 Apr; 50(5):678-80. PubMed ID: 17394511
[No Abstract] [Full Text] [Related]
15. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
16. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
[TBL] [Abstract][Full Text] [Related]
17. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
[TBL] [Abstract][Full Text] [Related]
19. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
Küfer R; Hautmann R
Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
[No Abstract] [Full Text] [Related]
20. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
